Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity
Rachid Essalmani, Jaspreet Jain, Delia Susan‐Resiga, et al.
Journal of Virology (2022) Vol. 96, Iss. 8
Open Access | Times Cited: 134

Showing 1-25 of 134 citing articles:

Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
Cell (2024) Vol. 187, Iss. 3, pp. 585-595.e6
Open Access | Times Cited: 105
Immune Evasion, Infectivity, and Fusogenicity of SARS-CoV-2 Omicron BA.2.86 and FLip Variants
Panke Qu, Kai Xu, Julia N. Faraone, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 46
Structural dynamics in the evolution of SARS-CoV-2 spike glycoprotein
Valeria Calvaresi, Antoni G. Wrobel, Joanna Toporowska, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 44
COVID-19 drug discovery and treatment options
Jasper Fuk‐Woo Chan, Shuofeng Yuan, Hin Chu, et al.
Nature Reviews Microbiology (2024) Vol. 22, Iss. 7, pp. 391-407
Closed Access | Times Cited: 20
Expanding Biology of PCSK9: Roles in Atherosclerosis and Beyond
Nabil G. Seidah, Damien Garçon
Current Atherosclerosis Reports (2022) Vol. 24, Iss. 10, pp. 821-830
Open Access | Times Cited: 55
SARS-CoV-2 evolved variants optimize binding to cellular glycocalyx
Sang Hoon Kim, Fiona L. Kearns, Mia A. Rosenfeld, et al.
Cell Reports Physical Science (2023) Vol. 4, Iss. 4, pp. 101346-101346
Open Access | Times Cited: 41
Immune-Boosting and Antiviral Effects of Antioxidants in COVID-19 Pneumonia: A Therapeutic Perspective
Stefano Sanduzzi Zamparelli, Alessandro Sanduzzi, Marialuisa Bocchino
Life (2025) Vol. 15, Iss. 1, pp. 113-113
Open Access | Times Cited: 1
Combinations of Host- and Virus-Targeting Antiviral Drugs Confer Synergistic Suppression of SARS-CoV-2
Jessica Wagoner, Shawn Herring, Tien-Ying Hsiang, et al.
Microbiology Spectrum (2022) Vol. 10, Iss. 5
Open Access | Times Cited: 36
Role of Dipeptidyl Peptidase-4 (DPP4) on COVID-19 Physiopathology
Alba Sebastián-Martín, Belén G. Sánchez, José María Mora-Rodríguez, et al.
Biomedicines (2022) Vol. 10, Iss. 8, pp. 2026-2026
Open Access | Times Cited: 32
O-Linked Sialoglycans Modulate the Proteolysis of SARS-CoV-2 Spike and Likely Contribute to the Mutational Trajectory in Variants of Concern
Edgar González-Rodríguez, Mia Zol-Hanlon, Ganka Bineva‐Todd, et al.
ACS Central Science (2023) Vol. 9, Iss. 3, pp. 393-404
Open Access | Times Cited: 22
Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses
Xiuyuan Ou, Ge Xu, Pei Li, et al.
Cell Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 21
SARS-CoV-2 Spike Protein Is Capable of Inducing Cell–Cell Fusions Independent from Its Receptor ACE2 and This Activity Can Be Impaired by Furin Inhibitors or a Subset of Monoclonal Antibodies
Nina Reuter, Xiaohan Chen, Barbara Kropff, et al.
Viruses (2023) Vol. 15, Iss. 7, pp. 1500-1500
Open Access | Times Cited: 20
Application of single-cell RNA sequencing on human testicular samples: a comprehensive review
Fan Dong, Ping Ping, Yi Ma, et al.
International Journal of Biological Sciences (2023) Vol. 19, Iss. 7, pp. 2167-2197
Open Access | Times Cited: 18
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity
Harry Ridgway, Charalampos Ntallis, Christos T. Chasapis, et al.
Viruses (2023) Vol. 15, Iss. 2, pp. 309-309
Open Access | Times Cited: 17
Precision nutrition to reset virus-induced human metabolic reprogramming and dysregulation (HMRD) in long-COVID
A. Satyanarayan Naidu, Chin‐Kun Wang, Pingfan Rao, et al.
npj Science of Food (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 8
Functional and antigenic characterization of SARS-CoV-2 spike fusion peptide by deep mutational scanning
Ruipeng Lei, Enya Qing, Abby Odle, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Targeting furin, a cellular proprotein convertase, for COVID-19 prevention and therapeutics
Xia Jiang, Dabing Li, Mazaher Maghsoudloo, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104026-104026
Closed Access | Times Cited: 6
Native and activated antithrombin inhibits TMPRSS2 activity and SARS‐CoV‐2 infection
Lukas Wettstein, Patrick Immenschuh, Tatjana Weil, et al.
Journal of Medical Virology (2022) Vol. 95, Iss. 1
Open Access | Times Cited: 23
Quercetin inhibits SARS-CoV-2 infection and prevents syncytium formation by cells co-expressing the viral spike protein and human ACE2
Annie Roy, Mcw Chan, Logan Banadyga, et al.
Virology Journal (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 5
Therapeutic development targeting host heparan sulfate proteoglycan in SARS-CoV-2 infection
Qi Zhang, Ivan Pavlinov, Yihong Ye, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 5
Transmembrane serine protease TMPRSS2 implicated in SARS-CoV-2 infection is autoactivated intracellularly and requires N-glycosylation for regulation
Yikai Zhang, Shijin Sun, Chunyu Du, et al.
Journal of Biological Chemistry (2022) Vol. 298, Iss. 12, pp. 102643-102643
Open Access | Times Cited: 22
Multi-omics for COVID-19: driving development of therapeutics and vaccines
Mengyu Guo, Muya Xiong, Jinying Peng, et al.
National Science Review (2023) Vol. 10, Iss. 9
Open Access | Times Cited: 12
Aprotinin—Drug against Respiratory Diseases
Alexandre V. Ivachtchenko, Andrey A. Ivashchenko, Dmitrii O. Shkil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11173-11173
Open Access | Times Cited: 11
Therapeutic antibodies and alternative formats against SARS-CoV-2
Rahel R. Winiger, Laurent Perez
Antiviral Research (2024) Vol. 223, pp. 105820-105820
Open Access | Times Cited: 4
Establishment of replication-competent vesicular stomatitis virus recapitulating SADS-CoV entry
Zihui Zhu, Yutong Han, Mingli Gong, et al.
Journal of Virology (2024) Vol. 98, Iss. 5
Closed Access | Times Cited: 4
Page 1 - Next Page

Scroll to top